Tax News Update    Email this document    Print this document  

March 10, 2023
2023-0455

House Energy and Commerce Subcommittee on Health advances five bills addressing health care, controlled substances, and suicide prevention

On March 8, the House Energy & Commerce Subcommittee on Health advanced five bills on health care, the new suicide prevention lifeline, and controlled substances. The bills now go to the full House Energy and Commerce Committee.

Three of the bills advanced aim to address the fentanyl crisis by adding new requirements for drug manufacturers, distributors and the Drug Enforcement Agency regarding suspicious orders of controlled substances; classifying fentanyl-related substances as a schedule I drug; and amending the Public Health Services Act to expand Title 42 to allow the Health and Human Services (HHS) Secretary to suspend persons or imports related to certain controlled substances from certain countries. The subcommittee also advanced a bill to ban the use of quality-adjusted life years (QALYs) from being used in determining coverage, reimbursement, or incentive program thresholds for all federal health care programs, as well as a bill to protect the 988 suicide hotline from cyber threats.

More information is available here.

Additional information is also available in the attached Tax Alert.

———————————————

Contact Information
For additional information concerning this Alert, please contact:
 
Washington Council Ernst & Young
   • Heather Meade (heather.meade@ey.com)
   • Heather Bell (heather.bell@ey.com)

____________________________

ATTACHMENT

Subcommittee on Health advanced bills

 

The information contained herein is general in nature and is not intended, and should not be construed, as legal, accounting or tax advice or opinion provided by Ernst & Young LLP to the reader. The reader also is cautioned that this material may not be applicable to, or suitable for, the reader's specific circumstances or needs, and may require consideration of non-tax and other tax factors if any action is to be contemplated. The reader should contact his or her Ernst & Young LLP or other tax professional prior to taking any action based upon this information. Ernst & Young LLP assumes no obligation to inform the reader of any changes in tax laws or other factors that could affect the information contained herein.

 

Copyright © 1996 – 2024, Ernst & Young LLP

 

All rights reserved. No part of this document may be reproduced, retransmitted or otherwise redistributed in any form or by any means, electronic or mechanical, including by photocopying, facsimile transmission, recording, rekeying, or using any information storage and retrieval system, without written permission from Ernst & Young LLP.

 

EY US Tax News Update Master Agreement | EY Privacy Statement